Cite
Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections
MLA
Jens H. Kuhn, et al. “Post-Exposure Prophylactic Vaccine Candidates for the Treatment of Human Risk Group 4 Pathogen Infections.” Expert Review of Vaccines, vol. 19, Jan. 2020, pp. 85–103. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....af727717aa560451ad55b2abf76107d4&authtype=sso&custid=ns315887.
APA
Jens H. Kuhn, Ian Crozier, Peter B. Jahrling, & James Logue. (2020). Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections. Expert Review of Vaccines, 19, 85–103.
Chicago
Jens H. Kuhn, Ian Crozier, Peter B. Jahrling, and James Logue. 2020. “Post-Exposure Prophylactic Vaccine Candidates for the Treatment of Human Risk Group 4 Pathogen Infections.” Expert Review of Vaccines 19 (January): 85–103. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....af727717aa560451ad55b2abf76107d4&authtype=sso&custid=ns315887.